Therapeutic use of calpeptin in COVID-19 infection.
This perspective considers the benefits of the potential future use of the cell permeant calpain inhibitor, calpeptin, as a drug to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Recent work has reported calpeptin's capacity to inhibit entry of the virus into cell...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Portland Press
2022
|
| Subjects: | |
| Online Access: | https://repository.londonmet.ac.uk/7994/2/cs-2022-0638.pdf |